Betina T. Blak

Generalisability of The Health Improvement Network (THIN) database:demographics, chronic disease prevalence and mortality rates

Betina T. Blak, Mary Ann Thompson, Hassy Dattani et al. · Journal of Innovation in Health Informatics · 2011 · 646 citations · Full text

Social Sciences, Health Sciences, Health Demography +16

Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs

Carolyn S.P. Lam, Shun Kohsaka, Avraham Karasik et al. · Journal of the American College of Cardiology · 2018 · 466 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

The importance of defining periods of complete mortality reporting for research using automated data from primary care

Andrew Maguire, Betina T. Blak, Mary Ann Thompson · Pharmacoepidemiology and Drug Safety · 2008 · 311 citations

Social Sciences, Health Informatics, Clinical Epidemiology +16

SGLT-2 Inhibitors and Cardiovascular Risk

Matthew A. Cavender, Anna Norhammar, Kåre I. Birkeland et al. · Journal of the American College of Cardiology · 2018 · 129 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort study

Shun Kohsaka, Carolyn S.P. Lam, Dae Jung Kim et al. · The Lancet Diabetes & Endocrinology · 2020 · 93 citations · Full text

Medicine, Cardiology, Pharmacology +12